Sofinnova Raises €472m To Build Europe’s Biggest Early-Stage Investment Fund

Reflects Booming Global Life Sciences VC Sector

 
• By Andrew McConaghie
  
Euros in test tube
Investment in Europe's sector is growing fast, with global biopharma VC fundraising set to break records in 2021. • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip